Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry by Choinière, M. et al.
Research Article
Development and Implementation of a Registry of
Patients Attending Multidisciplinary Pain Treatment Clinics:
The Quebec Pain Registry
M. Choinière,1,2,3,4 M. A. Ware,4,5,6,7 M. G. Pagé,1,3 A. Lacasse,1,4,8
H. Lanctôt,1,2 N. Beaudet,4,9 A. Boulanger,3,4,10,11 P. Bourgault,4,12 C. Cloutier,13,14,15
L. Coupal,16 Y. De Koninck,4,17,18 D. Dion,1,2,19 P. Dolbec,20,21 L. Germain,1
V. Martin,1 P. Sarret,4,22 Y. Shir,4,5,7 M.-C. Taillefer,1,2 B. Tousignant,20,21,23
A. Trépanier,1 and R. Truchon20,23,24
1 Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC, Canada
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The Quebec Pain Registry (QPR) is a large research database of patients suffering from various chronic pain (CP) syndromes
who were referred to one of five tertiary care centres in the province of Quebec (Canada). Patients were monitored using
common demographics, identical clinical descriptors, and uniform validated outcomes. This paper describes the development,
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implementation, and research potential of the QPR. Between 2008 and 2013, 6902 patients were enrolled in the QPR, and data
were collected prior to their first visit at the pain clinic and six months later. More than 90% of them (mean age ± SD: 52.76 ±
4.60, females: 59.1%) consented that their QPR data be used for research purposes. The results suggest that, compared to patients
with serious chronic medical disorders, CP patients referred to tertiary care clinics are more severely impaired in multiple domains
including emotional and physical functioning. The QPR is also a powerful and comprehensive tool for conducting research in a
“real-world” context with 27 observational studies and satellite research projects which have been completed or are underway. It
contains data on the clinical evolution of thousands of patients and provides the opportunity of answering important research
questions on various aspects of CP (or specific pain syndromes) and its management.
1. Introduction
In the field of pain research, like in other medical fields,
randomized controlled trials (RCTs) are the gold standard
for establishing the efficacy of interventions. However, RCTs
have several limitations [1–8]. Typically, patients are selected
according to strict criteria, and the interventions are assessed
under highly controlled conditions such that the obtained
results are often poorly generalizable to everyday practices.
Furthermore, RCTs are usually limited in time and sample
sizes may be too small to detect serious adverse effects. In
order to fill in these critical gaps in evidence for establishing
best practices in pain management, patient registries and
other forms of electronic healthcare databases represent
valuable options [1, 3, 4, 6].
A patient registry is defined as “an organized system
that uses observational study methods to collect uniform
data (clinical and other) to evaluate specified outcomes for
a population defined by a particular disease, condition or
exposure, and that serves a predetermined scientific, clinical
or policy purpose(s)” [2]. Patient registries contain “real-
world” data generated during the course of patient care that
can complement RCT findings. They can provide valuable
information for determining the clinical effectiveness and
safety of interventionswhenused in a diverse array of patients
(e.g., variable age, multiple comorbidities) and clinical set-
tings. Patient registries can also be designed to (1) describe
the progression of diseases, (2) monitor quality of care, (3)
assess the cost-effectiveness of treatments, or (4) conduct
outcome research studies [1–3]. Although they also have their
limitations [1, 2, 4], patient registries represent interesting
and alternative research avenues and are becoming more and
more popular in subspecialities of pain medicine including
management of acute postoperative pain (e.g., [9]), rheumatic
diseases [10, 11], low back pain (e.g., [12]), and neuropathic
pain (e.g., [13, 14]) as well as pain rehabilitation (e.g., [15])
and military-specific pain services (e.g., [16] to name just a
few.
In 2008, the Health Ministry of the province of Quebec
(Canada) designated four Pain Centres of Expertise within
the Montreal, McGill, Sherbrooke, and Laval University
Health Networks which altogether cover the entire province.
The Ministry wished to monitor the clinical outcomes of
patients treated in these newly designated centres (and
especially in tertiary care pain clinics) and obtain relevant
administrative statistics. In parallel, one of the strategic plans
of the Quebec Pain Research Network for 2007–2011 was to
develop a province-wide clinical pain research infrastructure
to facilitate the conduct of large observational and clinical
studies. Tomeet the objectives of both of these organizations,
there was a need to develop a uniform multisite registry that
documents the clinical condition and evolution of patients
treated in tertiary care pain clinics. This gave the impetus
to implement in the Quebec Pain Registry (QPR) project
designed to serve both clinical/administrative and research
purposes. To our knowledge, only two other registries of
patients with various types of chronic pain disorders treated
in multidisciplinary clinics have been developed so far, one
in the UK (Pain Audit Collection System) [17] (PACS) and
one in the US (Collaborative Health Outcomes Information
Registry (CHOIR) [18]). However, their data collection pro-
cedures differ from those used in the QPR whose content
is also richer in terms of clinical/medical data and outcome
measures.
The present paper describes how the QPR was developed
and implemented detailing its strength and shortcomings
with the aim of facilitating the creation of other pain patient
registries. The QPR structure and content are also presented
along with the characteristics of the enrolled patients. The
policy and procedures for accessing QPR data sets for
research purposes are described as well as the type of access
requests made.
2. Methods
2.1. Aims of the QPR. The aims of the QPR project were to (1)
put in place a prospective web-based registry of ambulatory
patients suffering from various types of pain syndromes
who were referred for multidisciplinary treatment in large
university-affiliated pain clinics in the province of Quebec,
(2) assess and monitor their condition over time using
common demographics, identical clinical descriptors, and
uniform outcomes measured with standardized/validated
measurement tools in each participating site, (3) document
pain treatments patients received and/or used over time,
(4) provide clinicians with a summary of the individual
condition of their patients along with useful administrative
statistics for their pain treatment facility, and (5) provide
reliable “real-world” data to researchers wishing to answer
important research questions or test hypotheses regarding
various aspects of chronic pain (or specific pain syndromes)
and its management, to assess study feasibility, and to facili-
tate and speed up patient recruitment in research projects or
clinical trials.
2.2. Development and Implementation. Using the guidelines
proposed by Solomon et al. (1991) [19] and Gliklich and
Dreyer (2007) [20], the development and implementation of
the QPR involved two distinct phases.
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2.2.1. Phase I: Choice of the Variables/Outcomes/Measurement
Tools and Pilot Study. The choice of items to be included in
the QPR was made with the objective of creating a uniform
minimal needs-based data set. The item choice had to be
balanced between the clinicians’ and researchers’ interests
for large amount of data, the burden placed on the patients,
and the time/costs associated with the data collection
process.
Demographic and Clinical Variables. All medical directors
of large Canadian university-affiliated pain treatment clinics
were contacted to share the questionnaires they used to
record patients’ demographics and clinical data (e.g., types of
current and past pharmacological and nonpharmacological
treatments received, drug adverse effects, and comorbidities)
at the first visit in their facility and at follow-up time(s).These
questionnaires were carefully reviewed by one researcher
(M.C.), one pain clinician (D.D.), and a research nurse
coordinator (H.L.) who selected the items to be included
in the QPR based on recurrence of their appearance across
questionnaires along with what they considered as the most
optimal question formulation and categories of responses to
measure these variables. Canadian andQuebec governmental
health surveys (Statistics Canada [21], Institut de la Statistique
duQuébec [22]) were also reviewed to ensure uniformity with
their coding system whenever possible (e.g., ethnicity, civil
status).
All the above information except for patient sociode-
mographics was incorporated into a single questionnaire
named the Initial Nurse-administered Questionnaire. A sec-
ond questionnaire was also developed using the approach
described above in order to collect follow-up data after
the patients’ first visit at the pain clinic (6-Month Nurse-
administered Questionnaire).
With regard to patient pain diagnoses to be established
by the pain physicians at the participating sites, it was felt
that the International Classification of Diseases (ICD-9 or 10
systems) [23, 24] did not provide precise diagnostic codes
for pain syndromes while the use of the coding system
of the International Association for the Study of Pain [25]
was viewed as too complicated and not practical in real-life
clinical settings. Therefore, four experienced pain physicians
with background in anesthesiology or neurosurgery who
have been working for more than 15 years in tertiary care
pain clinics in the province of Quebec and who took part
in the later phases of the QPR (A.B., C.C., P.D., and Y.S.)
were invited to elaborate a comprehensive and consensual
grid of pain diagnoses to which were assigned codes based
on the location of the pain (e.g., thoracic pain, generalized
pain syndrome), the type of disorder (e.g., postmastectomy
pain, and fibromyalgia), and/or its suspected etiology (e.g.,
disc disorder, pain following chemotherapy/radiotherapy).
The DN4 Questionnaire was also added to screen for the
presence/absence of a neuropathic pain component [26]. In
order to ensure uniformity in data collection for the type
of medical interventions carried out at the pain clinic (e.g.,
blocks, epidural injections, and neurolysis), the clinicians
elaborated a second grid which listed the possible interven-
tions to which were assigned different codes.
Patient Outcomes. Different sources of information such
as the recommendations made by the Initiative on Meth-
ods, Measurement, and Pain Assessment in Clinical Trials
(IMMPACT) Group [27, 28] guided the choice of the core
outcome domains and measurement tools to be included in
the QPR. A comprehensive review of the scientific literature
was also carried out by a postdoctoral fellow (M-C.T) under
the supervision of M.C. in order to list the strengths and
limitations of existing validated instruments in English and
French language to measure (1) pain characteristics (e.g.,
intensity, interference), (2) emotional well-being, (3) health-
related quality of life, (4) treatment expectations, and (5)
perceived improvement and treatment satisfaction. Accessi-
bility to normative data, respondent burden, and research
experience gained through the multisite Canadian STOP-
PAIN Project [29] were also factors that were considered
in the selection of measurement tools. In the few cases
where a validated French version of the Englishmeasurement
tool was not available (e.g., Chronic Pain Sleep Inven-
tory [30]), the items were translated into French using a
forward-backward method of translation [31]. The ques-
tionnaires/scales selected through the above process were
then assembled into two questionnaires named the Initial
Patient self-administered Questionnaire and the 6-Month
Patient self-administered Questionnaire. All the question-
naires were then distributed to the different members of the
QPR team (clinicians and researchers) for a final round of
comments.
Paper Case Report Forms (CRFs) were then prepared
and used in a pilot prospective study to test the feasibility
of implementing/running the QPR. Additional pieces of
information were collected during the pilot study such as
the time taken to complete each questionnaires/interview,
patients’ perceived degree of difficulty for filling out the
questionnaires, and clinical usefulness of the collected mate-
rial. Physicians were also asked to check the items they
would like to be included in a clinical summary form. After
having obtained institutional ethic approval of the research
protocol, the pilot study was conducted in 2007-2008 with
90 consecutive patients recruited in three multidisciplinary
pain treatment facilities which were candidates for becoming
the designated tertiary care clinics of the Quebec Pain
Centres of Expertise. These clinics were, respectively, located
at theCentre Hospitalier de l’Université deMontréal (CHUM),
McGill University Health Centre (MUHC), and Centre Hos-
pitalier de l’Université de Sherbrooke (CHUS). Once patients
provided informed consent, the QPR questionnaires were
administered to them prior to their first visit at the pain
clinic and six months later. All the data collected in this pilot
study were analysed using descriptive statistics. The results
of these analyses along with the comments/suggestions from
the stakeholders (unpublished data) were summarized by
the two principal investigators (PIs) of the QPR project
(M.C., M.W.) along with D.D. and H.L. and were used to
develop the final versions of the QPR questionnaires and
clinical summary forms, adjust the procedures to maximize
patients’ responsiveness and retention at follow-up, and
ensure optimal collaboration of the pain clinicians in the
project.
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QPR Measures and Tools. Table 1 lists the demographic
variables, clinical data, patient outcomes, and measure-
ment tools used in the QPR along with some admin-
istrative data obtained from the patients’ medical record
(e.g., time elapsed between referral and first visit at the
pain clinic). Information is also available on the QPR web
site (http://www.quebecpainregistry.com). Several items con-
tained in the original version of the registry were withdrawn
at the end of June 2012 (see Table 1) to reduce staff costs.
Based on the results of a survey carried out among the QPR
users in the preceding months, it was felt relevant to add one
instrument which was increasingly used to assess the risk
of opioid abuse, that is, the Opioid Risk Tool [32, 33]. On
the same occasion, the pain diagnostic grid and the medical
intervention grid were reviewed to include additional codes.
Copies of these grids are reproduced in the supplementary
files (see supplementary files in Supplementary Material
available online at https://doi.org/10.1155/2017/8123812) of the
online version of the present article.
Development of the Web-Based QPR Database. Dacima Soft-
ware Inc. (Montreal, Quebec, Canada; http://www.dacimas-
oftware.com) developed, tested, hosted, and maintained the
central web-based quality-controlled QPR database which
was FDA 21 CFR 11-compliant. They also developed the
electronic CRFs and database-generated clinical summary
forms which were beta tested by the Registry Nurse Coor-
dinator (H.L.) and her assistant (L.G.). In April 2012, the
QPR central database was transferred to Typhon Solutions
Inc. (Montreal, Quebec, Canada; http://typhonsolutions.ca)
who also developed and updated the electronic CRFs and
clinical summary forms. System access controls were in place
for registered users from the participating sites. Access to
the central anonymized database was limited to authorized
staff (e.g., biostatistician). Each patient was given a unique
code number in the database which was not linked to her/his
medical record.All the names, addresses, and phone numbers
of the participants along with their unique code number were
kept in each participating site in a separate and password
secured Excel file which was accessible only to the RN and
RA.This was aimed at preventing the transmission of specific
patient identifiers in the central data repository.
2.2.2. Phase II: Implementation, Data Collection,
and Quality Monitoring
Ethics Approval. The protocol, questionnaires, and proce-
dures for implementing theQPR in themultidisciplinary pain
clinics of the CHUM, MUHC, and CHUS were approved in
2008 by the REB of the CHUM which acted as the central
ethic committee in charge of obtaining approval from the
local ones. Given that the designation of the tertiary care
pain clinics affiliated to the Pain Center of Expertise of
Laval University (Quebec City, Canada) (Centre Hospitalier
Universitaire de Québec (CHUQ) and theHôtel-Dieu de Lévis
(HDL)) was considerably delayed for administrative reasons,
ethic approval was obtained only in 2012 for implementation
of the QPR in these two sites.
Implementation of the QPR. The QPR was implemented at
the multidisciplinary pain treatment clinics of the CHUM,
CHUS, and MUHC in November 2008, January 2009, and
March 2009, respectively. At the HDL, the QPR project
started in July 2012, and in August 2012 at the CHUQ.
Due to a restructuring of the Pain Center of Expertise of
the Sherbrooke University Health Network, enrolment of
new patients in the QPR had to be stopped at the pain
clinic of the CHUS in August 2012 but 6-month follow-up
measures were collected up to February 2013. In each clinic,
patient pain management was personalized and involved
various types of pharmacological (e.g., opioids, antidepres-
sants, and anticonvulsivants), interventional (e.g., nerve
blocks, epidural injections), physical (e.g., physiotherapy,
electrostimulation), and/or psychological (e.g., cognitive-
behavioral therapy) modalities as well as teaching of self-
management techniques (e.g., relaxation, distraction, and
sleep hygiene). Patients could be seen by professionals from
various disciplines at the pain clinic including anesthesiology,
family medicine, neurology, nursing, pharmacy, physiatry,
psychology, psychiatry, and physiotherapy. Choice of the
treatment modalities was based on the patients’ needs and
varied from one to the other.
Patient Enrolment. Consecutive ambulatory patients sched-
uled for a first visit at the pain clinic for multidisciplinary
pain treatment considerations were enrolled in the QPR if
they were (1) aged ≥ 18 years and (2) able to understand and
read French or English. Patients whowere unable to complete
questionnaires due to severe physical or cognitive inability
were excluded. Patients who were eligible for enrolment
in the preexisting registry of fibromyalgia patients [34] at
the MUHC pain clinic only were also excluded. Eligible
patients were informed that the information collected with
the QPR questionnaires before their first appointment and
at follow-up(s) was needed for clinical purposes (production
of a summary of their clinical condition for the physician
with whom they had an appointment) and administrative
endeavors (production of annual anonymized statistics).
Patients were also informed that their data along with those
of other patients who gave their permission could be used for
research purposes. If they agreed, they were invited to sign
the REB-approved consent form of the QPR.
Data Collection Procedures. Once the patients’ first appoint-
ment was fixed, the receptionist of the pain clinic faxed
their contact information to the Registry Assistant (RA) who
contacted them to explain the QPR procedures and confirm
their eligibility. She informed them that they would receive
by mail the Initial Patient Questionnaire along with the QPR
consent form and a preaddressed/stamped envelope. At the
time the QPR was implemented in 2008, e-technologies such
as IPad, IPhone, and other android devices were not widely
spread in the province and a substantial number of patients
did not have access to Internet yet. For those who did, they
were sent by e-mail an electronic copy of the Patient Ques-
tionnaire that they completed on screen. Patients were told
that completion of the questionnaire would require 20–30
minutes of their time and that the Registry Nurse will contact
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Table 1: Variables, outcomes, and measurement tools of the Quebec Pain Registry at each time point.
Variables/outcomes collected with the Patient self-administered Questionnaire (QP) and the
Nurse-administered Questionnaire (NQ) Initial visit 6-month follow-up
∗
Pain history
(i) NQ: pain duration X
(ii) NQ: circumstances surrounding the onset X
(iii) NQ: 1st degree family history of chronic pain𝜓 X
(iv) NQ: date and reason of referral, speciality of the referring doctor X
(v) NQ: number of pain-related visits to emergency (past 6 months) X X
(vi) NQ: number of pain-related hospitalizations (past 6 months) X X
(vii) NQ: time elapsed between consultation request and 1st visit at the Pain Clinic X
Pain characteristics
(i) NQ: frequency in the past 7 days (always, occasionally, no pain) X X
(ii) PQ: intensity (pain now, average, and worst pain in the past 7 days) (Numerical rating scale, 0 =
no pain, 10 = worst possible pain) [28] X X
(iii) NQ: quality (neuropathic pain component) (DN4 Questionnaire) [26] X X
(iv) PQ: pain interference on daily activities (Interference Items of the Brief Pain Inventory-10)
[44–46] X X
(v) NQ: impact of pain on sleep (Chronic Pain Sleep Inventory) [30] X X
(vi) NQ: mobility support required inside and/or outside the home X X
(vii) NQ: pain diagnosi(e)s established at the pain clinic: location, type, suspected etiology X X
Psychological well-being and quality of life
(i) PQ: depression (Beck Depression Inventory-1) [47, 48] X X
(ii) PQ: anger (numerical rating scale, 0 = not at all, 10 = extremely)𝜓 X X
(iii) PQ: tendency to catastrophize in the face of pain (Pain Catastrophizing Scale) [71, 72] X X
(iv) PQ: health-related quality of life (SF-12v2) [42, 43] X X
Pain treatments at the pain clinic or elsewhere
(i) NQ: current pharmacological pain treatment (prescribed and not prescribed): medication name
and posology X X
(ii) NQ: side effects of current pharmacological pain treatment: type and severity (categorical rating
scale, 0 = none, 4 = severe)𝜓 X X
(iii) NQ: past pharmacological pain treatment (prescribed and not prescribed): medication name
and reason(s) for stopping X X
(iv) NQ: type of current and past nonpharmacological pain treatments including interventions (e.g.,
injection therapy, surgery), psychological techniques (e.g., self-management program, individual
psychotherapy), self-management strategies (e.g., relaxation/breathing exercises, self-support
group), physical therapies (e.g., physiotherapy, electrostimulation, acupuncture), and
complementary alternative therapies
X X
(v) NQ: type of health care professionals consulted since pain onset and in the months preceding
follow-up X X
(vi) NQ: continuation of treatment at the pain clinic (yes, no) X X
(vii) NQ: patient’s disposition after treatment at the pain clinic X
Patient expectations regarding treatment at the pain clinic
(i) PQ: expected pain relief (Pain Relief Scale, 0% = no relief, 100% = complete relief) [73] X
(ii) PQ: patient expected global change regarding functioning level and quality of life (adapted from
the Patient Global Impression of Change Scale) [28] X
Patients’ perceived improvement and satisfaction with treatment at the pain clinic
(i) PQ: patient perception of pain relief (Pain Relief Scale, 0% = no relief, 100% = complete relief) [73] X
(ii) PQ: patient expected global impression of change regarding functioning level and quality of life
(Patient Global Impression of Change Scale) [28] X
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Table 1: Continued.
Variables/outcomes collected with the Patient self-administered Questionnaire (QP) and the
Nurse-administered Questionnaire (NQ) Initial visit 6-month follow-up
∗
(iii) PQ: patient satisfaction with treatment (Satisfaction Scale) [73]§ X
Medical history
(i) NQ: current and past medical history (type of disorders other than chronic pain) X X
(ii) NQ: type of current medication for medical condition X X
(iii) PQ: consumption habits (cigarettes, alcohol, illicit drugs) X X
(iv) PQ: risk of alcohol and drug abuse/misuse𝜓 (Cage-AID) [33, 74] X
(v) NQ: risk of opioid abuse/misusem (Opioid Risk Tool) [32, 33] X
Demographics
(i) PQ: date of birth X
(ii) PQ: sex X
(iii) PQ: ethnic group X
(iv) PQ: first language X
(v) PQ: education level X
(vi) PQ: current living conditions X X
(vii) PQ: civil status X X
(viii) PQ: current work status X X
(ix) PQ: family income X X
(x) PQ: main source of income X X
(xi) PQ: disability benefits X X
(xii) PQ: litigation regarding disability benefits X X
NQ, Nurse-administered Questionnaire; PQ, Patient self-administered Questionnaire (PQ).
∗Follow-up data were collected 6 months after patients’ initial visit at the pain clinic. Between November 2008 andMarch 2012, additional follow-up data were
gathered at 12 and 24 months but only in patients who had been not discharged from the pain clinic in the meantime.
𝜓Item not measured after June 2012.
mItem measured after June 2012.
§Patients were informed that no members of the clinical team will have access to their satisfaction ratings regarding the treatments they received at the pain
clinic.
them by phone prior to their first visit at the pain clinic. Upon
reception of the questionnaire, the RA carefully reviewed it
to make sure that all questions had been answered and if
not, the patient was contacted by phone. If the questionnaire
was not returned within the week preceding the scheduled
appointment at the pain clinic, the RA phoned the patient
and asked to bring it on the day of her/his appointment at
the pain clinic. Data collected with the Initial Patient Ques-
tionnaire were entered by the RA into the web-based QPR
portal.
The RA contacted the Registry Nurse (RN) who con-
ducted a structured telephone or face-to-face interview with
the patients in the days/hours preceding their first appoint-
ment at the pain clinic using the Initial Nurse Questionnaire.
Depending on the patient’s clinical condition, the interview
lasted between 30 and 90 minutes, and the information was
entered by the RN or RA into the online QPR database.
A summary of the patient’s clinical condition (e.g., pain
duration and intensity, and analgesic intake) was then gen-
erated from the database and transmitted to the treating
physician of the pain clinic. Follow-up data were collected
using the 6-Month Patient and Nurse Questionnaires using a
similar methodology as the one described above. Additional
follow-up data were gathered at 12 and 24 months after the
initial visit but only in those patients who had not been
discharged from the pain clinic in the meantime. These
data were collected with questionnaires containing the same
measures as those administered at the 6-month follow-up.
Due to financial considerations, follow-up data were not
collected at 12 and 24 months in newly enrolled patients after
March 2012. Due to budget cuts in the QPR project for the
year 2014-2015, collection of 6-month follow-up data had to
be interrupted in newly registered patients after June 2014,
and enrolment of new patients ended in November 2014.
In order to have a more complete picture of patient
pain management than the one provided in medical records,
all data about pharmacotherapy (prescribed and over-the-
counter medication) and nonpharmacological treatments
used inside and outside of the pain clinic (including com-
plementary alternative therapy) were collected by the Reg-
istry Nurses who did not have clinical duties in the QPR
participating sites. The purpose of having nurses rather
than RA for conducting the interviews with the patients
was twofold: (1) to ensure accuracy of the patient clinical
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summary transmitted to the treating physician at the pain
clinic and (2) to optimize the quality of the medical/clinical
data contained in the QPR database.
Quality Safeguards. Standard operating procedures (SOPs)
were prepared to standardize patient enrolment and data
collection, entry, and quality. Training of the QPR staff was
under the responsibility of the Registry Nurse Coordinator
and her assistant and consisted of a 2-day meeting during
which the SOPs were carefully reviewed, explained, and
illustratedwith examples andmock patient interviews. Phone
and e-mail follow-ups were made to maintain staff compe-
tency, inform them about modifications in the SOPs, and
answer questions. Onsite audits were also carried out in the
participating clinics to review screening/follow-up logs and
ensure procedural consistency across sites. Finally, all the
QPR staff attended a face-to-face meeting with the PIs and
the Coordinator at least once a year tomonitorQPR progress,
review the SOPs, and reiterate the high importance of data
completeness.
Quality monitoring of the QPR database was under the
responsibility of the Registry Nurse Coordinator and her
assistant. Each participating site was requested to provide a
monthly report of the number of patients enrolled in the
registry, reasons for exclusion, number of questionnaires
not completed and reasons why, losses to follow-up, and
so on. With regard to data quality monitoring, a series of
quality controls were programmed in the QPR database to
allow instant automated data validation checks (e.g., out-of-
range values, logical inconsistencies). To facilitatemedication
data entry and ensure consistency (e.g., generic versus brand
name), a medication dictionary was built in the database.
Manual data cleaning was also carried out on a regular
basis to identify discrepancies and missing data on variables
targeted as important (e.g., patient diagnosis, pain duration,
medication, and medical history) and to generate “queries”
to be sent to the participating sites for resolution. Statistical
programs to identify errors or inconsistencies on specific
measures were also part of quality control activities. Errors
identified when data were analysed for administrative or
research purposes were also corrected in the database.
2.3. Access Policy to QPR Data and Business Model
Access Policy. Once the QPRwas implemented, a comprehen-
sive policy to access/use data from QPR patients contained
in the registry and a business cost-recovery model were
developed by the two PIs of the present project (M.C., M.W.)
in collaboration with members of the Executive Committee
of the Quebec Pain Research Network (Y.D.K., P.S., and N.B.)
and legal/administrative advisers. The data access policy
received ethical approval from the central REB for the QPR
project at the CHUM and is available in the supplementary
files of the online version of the present article and on the
QPR website (http://www.quebecpainregistry.com).
Datasets of patients who gave informed consent can be
accessed for conducting observational studies. Assessment
of feasibility of research projects or clinical trials is also
possible (e.g., number of QPR female patients aged between
30 and 50 years with a diagnosis of complex regional pain
syndrome). The QPR can also be used to conduct “satellite”
research projects, that is, studies in which data contained in
the QPR (e.g., age, sex, and types of pain medication) are
linked to other sets of data (e.g., governmental administrative
databases, data collected in the context of a new study on vari-
ables other than the ones contained in the QPR). However,
the research protocol and the accompanying patient consent
form of the satellite projects have to receive prior approval
by the clinical team of the participating site(s), the central
REB of the CHUM, and the local REBs. Once the project is
approved by these authorities, the Medical Director of the
participating clinic(s) sends a letter to inform the eligible
QPR patients about the research project and invites them
if they are interested in participating to contact the person
in charge of the study or her/his representative. Finally,
the QPR data can be accessed to facilitate and speed up
patients’ recruitment in research projects or clinical trials; the
procedure is the same as the one used for satellite research
projects.
Business Model. The registry is an academic, not-for-profit
project. The business model relies on fees to cover (1)
administrative costs for running the data access requests
based on their complexity level (e.g., preparation of the
extraction/analysis plan, data extraction, statistical analyses,
and report preparation) and (2) financial contribution to
maintain the QPR data repository and ensure its long-term
sustainability. Access fees vary according to the type of
requesters, the lowest costs being for academic researchers
who are members of the Quebec Pain Research Network
(QPRN), followed by academic researchers who are not part
of the QPRN, and industry researchers whose companies
were or were not funding partners of the QPRN. Fees for
accessing QPR data also vary as a function of the number
of variables requested, complexity of the extraction process
and statistical analysis (if applicable), and whether they have
to be linked or not to external data sets (e.g., governmental
administrative database).
2.4. Analyses of the QPR Data. The total number of patients
enrolled in the QPR between November 1, 2008, and Decem-
ber 21, 2014, is 9363 (http://www.quebecpainregistry.com)
but the data included in the present article cover the period
during which new patients were enrolled in the QPR up to
December 31, 2013, and followed up at 6 months until to
June 30, 2014. Patients who did not give consent for their
QPR data to be used for research purposes were excluded
from the analyses. Data describing the clinical evolution of
the subgroup of patients with follow-up data not only at 6 but
also at 12 and 24 months have been presented at the Annual
Scientific Meeting of the Canadian Pain Society in 2014 [35]
and are in the process of being submitted for publication.
2.4.1. Missing Questionnaires. The number and percentages
of the Patient and Nurse Questionnaires which were com-
pleted prior to the initial visit at the pain clinic and at
6-month follow-up were computed. In order to assess if
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missing questionnaires qualified as “missing at random”
[2, 36], differences between completed questionnaires and
missing ones at each time point and between time points
were examined according to patients’ age using independent
Student 𝑡-tests. Chi-squared tests were carried out on differ-
ences between sex and participating pain clinics (study site).
However, such significant testing in studies involving large
sample sizes like the present one can be misleading because
even small differences can reach statistical significance while
they can be viewed as trivial and not meaningful clinically
[2, 37, 38]. Therefore, effect sizes of age differences between
patients who completed and did not complete the Patient or
Nurse Questionnaires at each time point were calculated with
Cohen’s 𝑑 [39]. Only differences which reached a medium to
large size effect as defined by Cohen [39] (i.e., a 𝑑 value ≥
±0.5) were considered meaningful [38]. For the variables sex
and study site, effect sizes were calculated using, respectively,
the Phi (𝜑) [40] and Cramér’s 𝑉 [41] statistics, and only
those which were in the moderate to strong range (i.e., a 𝜑
or Cramér’s 𝑉 value ≥ ±0.3) were judged as being clinically
important [2, 38].
2.4.2. Patients’ Characteristics. Descriptive statistics includ-
ing measures of central tendency (mean or median) and
dispersion (standard deviation or range) along with fre-
quency tables were used to document the characteristics of
the patients enrolled in the QPR. Due to space limitation,
only a subset of the variables in Table 1 which were believed
to provide a broad profile of the QPR patients at the time of
their first visit at the pain clinic were analysed in the present
article along with some data collected at 6-month follow-up.
Student’s 𝑡-tests were used to compare mean scores obtained
on the physical and mental summary scales of the SF-12v2
[42, 43] in QPR patients at their first visit at the pain clinic to
those of (1) the US healthy population (Canadian data being
currently unavailable) and (2) patients suffering from serious
chronic medical disorders other than chronic pain (cancer,
heart disease, and diabetes) [42].
2.4.3. Requests for Access to QPR Data. Descriptive statistics
were computed on the kind and number of requests made for
accessing QPR data and the type of users.
3. Results
3.1. Recruitment and Record Completeness. Of the 8,233
patients who were referred to the participating pain clinics
between November 2008 and December 2013 (inclusively),
7021 (85.3%) qualified for enrolment in the QPR and
only 1.7% refused to do so (Figure 1). Ninety-two percent
(6337/6902) consented that their QPR data be used for
research purposes. Given that the registry was implemented
in each participating site at different moments, the patient
distribution was variable between sites: CHUM: 𝑁 = 2052
(32.4%);MUHC:𝑁 = 2292 (36.2%); CHUS:𝑁 = 745 (11.8%);
CHUQ: 𝑁 = 810 (12.8%); HDL: 𝑁 = 438 (6.9%). The
percentages of patients who completed the Initial Patient and
Nurse Questionnaires were 98.5% and 99.2%, respectively.
Table 2: Demographic characteristics of the 6,337 patients enrolled
























Mixed race 81 1.3
Work status
Full-time work 1236 19.8
Part-time work 521 8.3
Temporary disability income 1212 19.4







At 6-month follow-up, 89.1% of the patients (5647/6337)
completed at least one of the two questionnaires (Figure 1).
Results of the statistical analysis for comparing participants
who completed and did not complete the questionnaires at
each time point and between time points revealed some
statistically significant differences with regard to age, sex,
and/or study site (𝑃 ≤ 0.05). However, all the effect sizes were
small (d values < 0.5; 𝜑 or Cramér’s𝑉 values < 0.3) suggesting
that the differences are not clinically meaningful [2, 38].
3.2. Characteristics of the QPR Patients. Patients enrolled
in the QPR during the study period were aged between 18
and 88 years (mean = 52.76, SD = 14.6), 59.1% were female,
and the vast majority (92.0%) were of Caucasian origin
(Table 2). Nearly half of them (46.1%) had a secondary level
of education or less. The percentage of patients who worked
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8233 patients were seen at the participating clinics between Nov 2008 and Dec 2013
1212 patients did not meet the selection criteria or were
missed (too long delay)
6337 patients were included in the study
(6188 patients completed both initial questionnaires; all 6337 patients completed at least 
one of the two questionnaires)
565 patients refuse to sign the research consent form
4151 patients completed the 6-month Patient Questionnaire
97 patients did not complete the initial Patient self-administered 
Questionnaire.
(i) 83 patients were missed (or too long delay).
(ii) 14 patients were temporarily physically or cognitively unable or 
refused at this time point.
52 patients did not complete the initial Nurse-administered 
Questionnaire.
(i) 42 patients were missed or could not be reached.
(ii) 3 patients were temporarily physically or cognitively unable 
or refused at this time point.
(iii) 7 patients: other reasons
410 patients were lost to 6-month follow-up.
(i) 193 patients did not receive any treatment and were
discharged after initial visit.
(ii) 114 patients were physically or cognitively unable to
further participate or refused.
(iii) 103 patients: other reasons (e.g., deceased, moved)
5927 patients were available to complete the 6-month follow-up questionnaires
(4025 patients completed both follow-up questionnaires; 
5647 patients completed at least one of the two questionnaires)
406 patients did not complete the 6-month Nurse Questionnaire.
(i) 269 patients were missed. 
(ii) 87 patients were unable or refused to answer the
questionnaire at this time point.
(iii) 50 patients: other reasons
1776 patients did not complete the 6-month Patient 
Questionnaires.
(i) 1271 patients were missed (or too long delay).
(ii) 446 patients were temporary physically or cognitively
unable or refused at this time point.
(iii) 59 patients: other reasons
5521 patients completed the 6-month Nurse Questionnaire
6240 patients completed the initial Patient Questionnaire 6285 patients completed the initial Nurse Questionnaire
119 patients refused to participate in the QPR
6902 patients were enrolled in the QPR
7021 patients were eligible to enroll in the QPR
Figure 1: Flow of participants through the QPR during the study period.
on a part-time or full-time basis was 28.1% while permanent
or temporary disability income was the unique source of
revenue for more than one-third of the patients (37.2%).
The median amount of time elapsed between patients’
referral and first visit at the pain clinic was 3.5 months; 35.0%
of the patients waited more than 6 months for their appoint-
ment, some of them (5.2%) having waited between 2 and 4
years (Table 3). Close to 40% of the patients (38.7%) were
referred at the pain clinic by their family physician while the
others by specialists from various surgical (e.g., orthopedics,
neurosurgery plastic surgery) or medical (e.g., neurology,
rheumatology, and physiatry) disciplines (data not shown).
Pain was present for 5 years or more in close to half of the
patients (46.6%) and less than 1 year in 13.1% (Table 3). Since
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Table 3: Pain-related characteristics of patients enrolled in the
Quebec Pain Registry up to December 31, 2013.
Mean SD
Average pain intensity in the past 7 days 6.71 2.0
Worst pain intensity in the past 7 days 8.16 1.8
Physical Health-Related QOL (SF-12v2)∗ 29.07 8.9
Mental Health-Related QOL (SF-12v2)∗ 40.48 11.7
𝑛 %
Evidence of neuropathic pain
(i) No𝜓 1336 23.9
(ii) Yes𝜓 1732 31.0
Mixed evidence𝜓 2511 45.0
Pain duration
(i) <1 year 702 13.1
(ii) 1 year to <3 years 1201 22.4
(iii) 3 years to <5 years 964 18.0
(iv) 5 years to <10 years 1098 20.4
(v) ≥10 years 1405 26.2
Time elapsed between referral and 1st visit
(i) <0.5 year 3603 65.0
(ii) 0.5 year to <2 years 1620 29.2
(iii) 2 years to <4 years 297 5.4
(iv) ≥4 years 23 0.4
Pain interference over the past 7 days (BPI
score ≥ 7/10)
(i) General activity 3684 59.1
(ii) Mood 2931 47.0
(iii) Walking ability 2789 44.7
(iv) Normal work 4016 64.4
(v) Relations with other people 2225 35.7
(vi) Sleep 3410 54.7
(vii) Enjoyment of life 2337 37.5
(viii) Self-care 1653 26.5
(ix) Recreational activities 4069 65.2
(x) Social activities 3275 52.5
Depressive symptoms (BDI-I)
(i) None or minimal (0–9) 1335 21.4
(ii) Mild (10–18) 2167 34.8
(iii) Moderate (19–29) 1786 28.7
(iv) Severe (30–63) 946 15.2
∗Norm-based scores [44].
𝜓Patients were classified as having nonneuropathic pain if they received a
nonneuropathic pain diagnosis from the pain physician and had a score ≤ 3
on the DN4Questionnaire. A diagnosis of neuropathic pain was defined as a
combination of a neuropathic pain diagnosis made by the pain clinician and
a score≥ 4 on theDN4. Patients who had either a neuropathic pain diagnosis
from the pain physician or a score ≥ 4 on the DN4 were classified as having
mixed evidence of neuropathic pain.
the onset of their pain, patients reported having consulted
between 1 and 23 different types of healthcare professionals
in medical (e.g., family medicine), physical (e.g., physical
therapy), counseling (e.g., psychology), and/or alternative
disciplines (e.g., acupuncture), the median value being 5.0
(data not shown).
An accident or a trauma was at the origin of the pain
in more than half of the cases (52.5%); 31.4% of the patients
reported that their pain occurred during or following an
illness or and 14.2% after a surgery while one patient out
of five (22.5%) was unable to associate the onset of her/his
their pain to any precise event. Figure 2 shows the top 10
pain diagnoses made by the physicians at the participating
pain clinics. Lumbar pain with and without radicular pain
was the most frequent one (28.6%), followed by fibromyalgia
(6.6%), and complex regional pain syndrome in the upper
limbs (5.7%). Based on both the clinicians’ pain diagnoses
and scores ≥ 4 obtained in the patient and physician portions
of the DN4 [26], 31.0% of the patients were suffering from
a neuropathic type of pain while the evidence was mixed in
45.0% of cases (i.e., the clinician diagnosed the patient with a
neuropathic pain disorder but the DN4 score was not ≥4, or
vice-versa) (Table 3).
The majority of the patients (85.0%) reported that their
pain was present continuously in the 7 days preceding their
first visit at the pain clinic. Mean pain intensity scores for
the “average” pain and “worse” pain during this time period
were 6.71 (SD = 2.0) and 8.16 (SD = 1.80), respectively.
Patients’ ratings on the interference scales of the Brief Pain
Inventory-10 [44–46] revealed that, for more than 50% of
them, pain severely impacted (scores ≥ 7/10) on various
aspects of their daily living including general activity, normal
work, sleep, and recreational and social activities (Table 3). A
similar pattern of results emerged on reported health-related
quality of life measured by the SF-12v2 [43].Themean norm-
based scores on the physical (29.07, SD = 8.90) and mental
summary scales of this questionnaire (40.48, SD = 11.70) were
significantly lower in our sample of patients suffering from
chronic pain compared not only to those obtained in the
US healthy population but also to patients suffering from
serious medical chronic disorders (Figure 3) (all P ≤ 0.001
and Cohen’s 𝑑 values between 0.6 and 3.3). With regard to
depression symptomatology, scores obtained on the Beck
Depression Inventory-I [47, 48] revealed signs of moderate
to severe depression in 43.9% of the QPR patients (Table 3).
When questioned about the expected percentage of pain
relief at six months after initiating treatment at the pain
clinic, more than half of the patients (53.4%) anticipated pain
relief ranging between 50 to 80% while one patient out of
four (25.0%) expected pain relief superior to 80%. A large
percentage of patients also anticipated that their functioning
level (63.4% of patients) and quality of life (65.3% of patients)
would be greatly or considerably improved over the next six
months.
3.3. Requests for Access to QPR Data. Table 4 shows the
number and type of research projects for which access to
QPR data has been requested up to February 2016. Of the 40
projects, one-half were or are currently conducted by grad-
uate students and post doc or medical fellows from various
disciplines including anesthesiology, biomedical sciences,
family medicine, neurosciences, pharmacology, psychology,
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Complex regional pain syndrome: lower limb
Other peripheral neuropathy: lower limb
Thoracic without radicular pain
Cervical and radicular pain
Diffuse pain in the lumbar region
Cervical without radicular pain
Complex regional pain syndrome: upper limb
Fibromyalgia
Lumbar without radicular pain
Lumbar and radicular pain
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Figure 2: Top 10 pain diagnoses made by the physicians of the pain clinics.












Patients with heart disease
Figure 3: Mean scores on the physical and mental summary scales
of the SF-12v2 in QPR patients (𝑛 = 6230), US healthy population
without a chronic condition (𝑛 = 1275), and patients suffering from
cancer (𝑛 = 246), diabetes (𝑛 = 530), and heart disease (𝑛 = 643)
[42]. QPR patients’ scores were compared to those of the other
groups using Student’s 𝑡-tests. All𝑃 values are< 0.001 and all Cohen’s
𝑑 values are ≥ 0.5.
and rehabilitation. Most of them consisted of observational
studies or satellite research projects on various aspects of
chronic pain or its management.The results of seven of these
studies have been published so far [49–55] or are under
review in peer-reviewed journals while others have been
presented in scientificmeetings [35, 56] and are in the process
of being submitted for publication. Finally, several academic
or industry researchers requested access toQPRdata to either
conduct studies or assess trial feasibility (Table 4).
4. Discussion
As shown in the present paper, developing and implementing
a multisite patient registry is a complex task. Although
maintaining a registry such as the QPR is very costly, we have
shown that it is feasible to collect uniform and reliable data
in a large number of tertiary care patients suffering from a
variety of pain syndromes and across different clinics. The
collected information can help clinicians in making their
diagnosis and management plan and can provide partici-
pating pain clinics with useful statistics on their practices.
In addition to documenting the characteristics and manage-
ment of patients referred to multidisciplinary pain clinics,
our results showed that the QPR made possible the conduct
of observational studies and satellite research projects using
“real-world” data on various aspects of chronic pain.
In terms of the feasibility of implementing the QPR,
our results showed that only 1.7% of the potentially eligible
patients refused to complete any questionnaires and 8.2% did
not consent that their data be used for research purposes.
Close to 100% of patients completed both the Initial Patient
Questionnaire and Nurse Questionnaire. At 6-month follow-
up, the percentage decreased but the overall retention rate
remained high; that is, nearly 90% completed at least one of
the two questionnaires. Some statistically significant differ-
ences were found in terms of patients’ age, sex, and study site
between thosewho did and did not answer the questionnaires
at each time point and between time points. However, all
effect sizes were not clinically meaningful suggesting that
missing questionnaires did not introduce bias in theQPRdata
[2, 38].
Compared to the majority of existing pain patient reg-
istries [9–16], the QPR is somewhat unique in that it covers a
wide variety of chronic pain disorders. Based on our literature
review, there are only two other longitudinal registries which
have been implemented in multidisciplinary pain treatment
clinics, that is, the PACS [17] (also named PainDB [57]) and
the CHOIR [18]. However, a validation study on the quality
of the PainDB concluded that this registry was unsuitable for
research purposes [57]. Implemented in 2012, that is, four
years after the QPR, the CHOIR (https://choir.stanford.edu)
[18] had several advantages including (1) extensive use of e-
technologies (web, IPad, and IPhone/android devices) and
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(i) Undergraduate 1 1
(ii) M.S. 3 — — — 3
(iii) Ph.D. 4 2 — — 6
(iv) Postdoctoral 2 2 — 1 5
(v) Research/clinical fellowship 3 1 — 1 5
Academic researchers 4 1 6 1 11
Industry researchers 4 — 1 1 6
Clinicians — — 2 — 2
Total 21 6 9 4 40
∗Satellite research projects are studies in which QPR data are linked to other data sets (e.g., governmental administrative databases) or to data obtained in the
context of a new study collecting variables not contained in the registry (see Section 2.3 – Access Policy).
(2) integration of item banks drawn from the National
Institutes of Health (NIH) Patient-Reported Outcomes Mea-
surement Information Systems (PROMIS) [58] which are
administered using an item-response theory approach [59,
60]. The outcome measures included in the CHOIR are also
collected using state-of-the-art computerized adaptive testing
(CAT) techniques [61, 62] allowing the identification of the
optimal items within each domain based on prior responses
from the patients thereby reducing respondent burden [18].
As a result, the CHOIR collection of patient-reported out-
comes is entirely electronic but more importantly the whole
process is much more sophisticated and efficient in the
CHOIR than it was in the QPR. The CHOIR outcome data
can be linked to electronic medical records (EMR) thereby
offering the possibility of point of care reporting to support
clinical decisions as well as the opportunity to conduct
multisite treatment effectiveness studies in a “real-world”
context as opposed to the strict and artificial conditions of
a RCT [18]. However, carrying out such a type of studies
is also possible with the QPR as illustrated in earlier QPR
publications on gabapentin on- and off-label use [50] and
effectiveness of long-term opioid therapy [63]. Furthermore,
the patients’ pain diagnoses contained in the QPR are much
more precise as they were established by pain specialist
physicians using a comprehensive grid rather than being
based on referral reason(s) or ICD-9 codes as it is the case
in the CHOIR studies [64, 65]. This is a major advantage
given the potential inaccuracy of diagnoses on the referral
form. For example, it has been found that only 34%of patients
referred for fibromyalgia actually do suffer from this disorder
[66]. A last advantage of the QPR is that it contains data
on pain modalities used by the patients inside and outside
of the pain clinic (e.g., over-the-counter medication, com-
plementary and alternative medicine therapies); those data
were collected by registered nurses during comprehensive
interviews. Although the QPR has several assets, they are also
revealed to be its Achilles heel due to the huge associated costs
in terms of human resources; those costs have compromised
its long-term sustainability and expansion to other sites. In
addition to the Registry Nurse Coordinator and her assistant,
QPR data collection and data cleaning required at least one
nurse and one administrative assistant working on a full-time
basis at each participating site. In spite of the fact that we
reduced the number of follow-up time points to only one
(i.e., 6 months after patients’ initial visit), the inclusion of two
additional sites coupled to budget cuts in our funding forced
us to stop enrolling new patients in the QPR although the
database still continues to be available for research purposes.
Enrolment of new patients was expected to be maintained
in the long-term based solely on the revenues generated by
data access requests from academic and industry researchers.
However, these revenues are revealed to be insufficient.
This may partly be the result of some delay in developing
the mechanisms for accessing rapidly and efficiently QPR
data and disseminating it to relevant audiences [19]. Other
registries appeared to either have a more sustainable business
model because of hospitalmembership fees and support from
associations [9, 67] or have an overall lowermaintenance cost
due to the use of electronic data collection systems linked to
ERM [18].
With regard to the characteristics of the participants
enrolled in the QPR prior to their first visit at the pain
clinic, our results highlight the fact that patients attending
tertiary care pain clinics are significantly impaired inmultiple
domains. The majority of patients experienced continuous
pain that reached intensity levels severe enough to interfere
substantially with various aspects of their daily living includ-
ing emotional well-being. Consistent with earlier results
obtained in a smaller sample [29], we observed that patients
reported poor health-related quality of life. The reported
decrease in physical and mental functioning is remarkable
when compared to the US healthy population and patients
suffering from other chronic disorders [42]. However, these
results are not that surprising when one considers that most
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patients are referred to tertiary care pain clinics once all other
resources have been exhausted [29]. Since their pain onset,
QPR patients reported having consulted up to more than 20
different types of healthcare professionals.
Interestingly, the median time elapsed between patients’
referral and first visit at the pain clinic was found to be 3.5
months. Eleven years ago, Veillette et al. (2005) examined
the waitlists of pain services across the province of Quebec
and found that two-thirds of the patients were waiting for 9
months ormore [68]. In a subsequent study, Peng et al. (2007)
reported that the median wait time for a first appointment
in the Quebec multidisciplinary pain treatment clinics was
around 8 months [69]. In the light of the results obtained
in the present study, it is tempting to speculate that local
initiatives to improve patients’ triaging [70] have contributed
to somewhat decrease the patient waitlists of participating
pain clinics.
In terms of expectations toward treatment, our results
revealed that close to 70% of the patients anticipated great or
considerable improvement in their functioning and quality
of life while one patient out of five was expecting 80–100%
pain relief following treatment at the pain clinic. Whether
such high expectations can be detrimental to patients’ out-
comes was recently investigated using the initial visit and 6-
month follow-up QPR data. The results of this study suggest
that individuals who expected positive changes were more
inclined to perceive improvements in their overall condition,
leading to superior clinical outcomes [49].
Although our above study findings are informative and
are based on a large sample size of patients followed prospec-
tively in several sites and in a real-world context, they
have limitations that should be acknowledged. First, they
characterized only a small proportion of the chronic pain
population, that is, those who are referred to tertiary care
clinics, such that the results cannot be generalized to other
populations of patients treated in primary or secondary care
settings. Second, it is important to point out that access to
tertiary care clinics in the province of Quebec requires a
physician referral; access to these clinics is free but limited
due to relatively long waiting lists as is the case in other
Canadian provinces [69]. As a result, it is unclear how
the data obtained in the QPR compare to what would be
obtained in other healthcare systems (self-referrals or other
systems of access to the specialized pain clinics). Finally, other
limitations of our findings pertain to the use of an observa-
tional data source in which sampling and confounding biases
may occur and thereby compromise validity of the conclu-
sions [1, 2, 4]. Although we made all efforts to minimize
missing questionnaires, we cannot exclude the possibility of
biases.
The present paper finally illustrates how “real-world”
patient registries such as the QPR can be valuable and
powerful research tools [1, 2, 6]. So far, 21 observational
studies on a variety of issues related to chronic pain have
been carried out with QPR data or are underway. Six satellite
research projects in which QPR data were interfaced with
other databases or data sets have also been conducted,
thereby minimizing duplicate data collection. As part of their
research training, several graduate and postgraduate students
used or are currently using QPR data to conduct research
projects, and the results of seven of them have been published
so far in peer-reviewed journals [49–55] or are under review.
5. Conclusions
The QPR is a vast registry of patients referred to multi-
disciplinary pain treatment clinics that was designed for
clinical/administrative and research purposes. This registry
provides numerous opportunities to study various aspects
of chronic pain (or specific pain syndromes) and its man-
agement using longitudinal “real-world” data on a large set
of variables collected in tertiary care patients. The most
important challenge posed by the QPR remains to be its
maintenance costs which have compromised its long-term
sustainability and its expansion in other pain clinics.
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